Drug intelligence / Profile preview

Taijing

Development stage: Preclinical
Modality: Small Molecules
Administration: Oral

Overview

Taijing is a pharmaceutical agent used for bowel preparation prior to colonoscopy. It is typically administered orally, often in conjunction with other laxatives such as polyethylene glycol (PEG) powder, to effectively cleanse the colon. Its primary function is to induce bowel movements, ensuring a clear view of the intestinal lining during the colonoscopy procedure.

Brand names: Taijing
Other names: 泰净

Beyond the preview

Go deeper on Taijing.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Taijing.

Explore the full profile